Pliant Therapeutics Inc. (PLRX) Stock Price

1.325 ▼ -0.035 (-2.57%)
Open: 1.34 Vol: 0 Day's range: 1.325 - 1.345 Apr 09, 10:40 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
PLRX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL BUY BUY NEUTRAL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.33▼ 1.34▼ 1.34▼ 1.33▼ 1.30▲
MA10 1.34▼ 1.34▼ 1.33▼ 1.28▲ 1.26▲
MA20 1.34▼ 1.33▼ 1.32▲ 1.30▲ 1.27▲
MA50 1.33▼ 1.33▼ 1.30▲ 1.26▲ 1.42▼
MA100 1.31▲ 1.28▲ 1.29▲ 1.31▲ 5.84▼
MA200 1.33▼ 1.29▲ 1.30▲ 1.43▼ 12.57▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.003▼ 0.000▲ 0.000▼ 0.006▲ 0.063▲
RSI 41.136▼ 49.506▼ 51.955▲ 53.291▲ 44.560▼
STOCH 13.889▼ 58.333     70.581     81.704▲ 63.634    
WILL %R -100.000▼ -75.000▼ -50.000     -22.917▲ -31.884    
CCI -162.893▼ -42.982     6.446     74.905     72.142    
Latest Filters Detected On PLRX
▲ GAP $PLRX Open Gap Up %2 Set Alert
CDL $PLRX Hanging Man Candlestick Pattern Detected Set Alert
Pliant Therapeutics Inc. News
Pliant Therapeutics Announces Upcoming Presentation of Phase 1 Clinical Trial of PLN-101095 in Patients with Solid Tumors at the 2026 AACR Annual Meeting
Wednesday, March 18, 2026 02:01 AM
SOUTH SAN FRANCISCO, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discovery and development of ...
Pliant Therapeutics Announces Upcoming Presentation of Phase 1 Clinical Trial of PLN-101095 in ...
Tuesday, March 17, 2026 05:00 PM
SOUTH SAN FRANCISCO, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discovery and development of ...
Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors
Thursday, December 04, 2025 04:30 AM
SOUTH SAN FRANCISCO, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced interim data from its Phase 1 dose escalation clinical trial evaluating ...
PLRX historical stock data
date open high low close volume
09/04/26 1.34 1.345 1.325 1.325 288,184
08/04/26 1.34 1.36 1.31 1.36 298,889
07/04/26 1.30 1.32 1.275 1.31 422,041
06/04/26 1.34 1.379 1.305 1.31 519,917
02/04/26 1.30 1.38 1.28 1.35 521,601
01/04/26 1.27 1.33 1.27 1.32 523,062
31/03/26 1.17 1.30 1.165 1.26 1,150,694
30/03/26 1.17 1.185 1.14 1.175 336,463
27/03/26 1.24 1.26 1.15 1.17 724,833
26/03/26 1.30 1.32 1.23 1.23 630,900
Quote Details
52wk Low:1.09
52wk High:1.95
Vol:0
Avg Vol(3m):9.7M
1Y Chng:-9.25%
1M Chng:+2.71%
Add to Watch List
More Information
Index US Composite
Market Cap. 81.11M